Potent New Weapon CDC Daily UpdateImportant note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




Potent New Weapon

Los Angeles Times--Washington Edition (12/15/95) P. A9
Cimons, Marlene


Protease inhibitors are an apparently effective new class of AIDS drugs that attack HIV at a later stage than the family of drugs known as nucleoside analogs do and cause a remarkable drop in the amount of virus detectable in HIV-infected patients' blood. However, like the older nucleoside analogs, such as AZT, ddI, ddC, D4T, and 3TC, protease inhibitors are also subject to drug resistance when the virus mutates into new forms. When taken in combination with other drugs, however, protease inhibitors can blunt the virus' ability to resist these and other drugs. At present, at least six protease inhibitors are undergoing various stages of development, and researchers predict that even stronger versions of this class of drugs may be in development soon.


951218
AD952251


Copyright © 1995 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.